ICAM1 and obstructive sleep apnea syndrome: By employing rigorous subgroup and meta-regression analyses, this work seeks to enhance the understanding of ICAM-1’s clinical significance as a biomarker for OSA and CVD risk while identifying factors contributing to heterogeneity in results.